Health TrialsbyHealthPanel

Intervention to Reduce Implicit Bias in Pharmacies

ConditionsBias, ImplicitHIVPre-exposure Prophylaxis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorMassachusetts General Hospital

About this trial

This study will follow the ADAPT-ITT model to apply the Prejudice Habit Breaking Intervention (PHBI) to pharmacists who have experience with or are willing to prescribe PrEP. We will first collect qualitative data through focus group discussions guided by the Health Equity Implementation Framework (HEIF) on determinants related to the intervention itself, pharmacists, and the community pharmacy context that may impact implementation of the PHBI. Then, we will use this information to adapt the PHBI in an iterative process involving topic experts, pharmacists, and PrEP users. We will then determine the feasibility, acceptability, and preliminary impact of the adapted PHBI to reduce implicit racial bias.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Pharmacy intern (non-licensed individual undergoing training and preparations for licensure examination).

Currently registered as a regular student in the School of Pharmacy, Bouvé College of Health Sciences at Northeastern University, Boston, MA.

Doing the internship in pharmacies located in cities with the highest average annual rate of HIV infection diagnosis in Suffolk County, MA.

Experience with PrEP (counsel PrEP candidates, complete PrEP continuing education activity, or awareness with current CDC guidelines on PrEP use) OR willingness to prescribe PrEP in the future (will be measured with one Yes/No question: "Are you willing to prescribe PrEP in the future?)

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • The adapted PHBI

    Behavioral

    The adapted intervention is expected to be an online 60-minute video with an educational part about implicit racial bias, its consequences in healthcare inequalities, how to mitigate it, and seven case scenarios (5 minutes each) to train pharmacy interns on aspects related to cultural competency and how and when to use IBMS to reduce the impact of bias on prescribing PrEP for people of color.

  • The NIH Implicit Bias course

    Behavioral

    The NIH Implicit Bias course consists of three modules designed to teach users what bias is, how to recognize it, and how to minimize its impact

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: The adapted PHBIExperimental treatment 1 intervention
Group B: NIH Implicit Bias courseActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Acceptability of the adapted intervention- Questionnaire

Acceptability will be assessed in all participants by the Acceptability of Intervention Measure (AIM)

Time frame
8 weeks
2

Feasibility of the adapted intervention- Questionnaire

Feasibility will be assessed in all participants by the Feasibility of Intervention Measure (FIM)

Time frame
8 weeks
3

Feasibility of the adapted intervention- Observed length of recruitment time

As a measure of feasibility, we will evaluate how many weeks are needed to recruit our desired study sample

Time frame
8 weeks
4

Feasibility of the adapted intervention- Self-reported video completion

As a measure of feasibility, we will measure the number strategy videos completed

Time frame
8 weeks

Secondary outcomes

1

Reduction of implicit racial bias

Impact of the intervention on reducing implicit bias among pharmacy interns will be assessed by the Race Implicit Association Test (IAT). In the IAT participants respond to items that are to be categorized into four groups: two representing racial groups (White vs. Black/Latinx) and two representing valences (negative vs. positive), which are presented in pairs. The concept is that when the social group and valence mapped onto the same response are strongly associated, individuals respond more quickly than when they are weakly associated. The IAT is graded using a D score ranging from -2.0 to 2.0 (the average D score αs =0.78). Scores between -0.15 and 0.15 are considered to represent no preference for Whites, 0.16 to 0.35 and 0.36 to 0.65 slight and moderate preference, and values greater than 0.65 in absolute value strong preference

Time frame
8 weeks
2

Concern about discrimination

Will be measured by using the Concern about Discrimination scale which is a 4-item questionnaire to measure participants' beliefs that discrimination is a problem in society. Responses to each item are rated on a scale of 1 (strongly disagree) to 10 (strongly agree). Responses are averaged with a high score indicating high concern and vice versa.

Time frame
8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Massachusetts General Hospital

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: